Apyx Medical (APYX) Change in Account Payables (2011 - 2026)
Apyx Medical (APYX) posted Change in Account Payables of -$411000.0 for Q1 2026, down 165.16% on a QoQ basis from -$155000.0 in Q4 2025, and down 24.17% year-over-year from -$541996.0 in Q1 2025.
Apyx Medical (APYX) Change in Account Payables (2011 - 2026) Analysis & Trends
Apyx Medical's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$411000.0 for Q1 2026.
- Quarterly Change in Account Payables fell 24.17% year-over-year to -$411000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $275000.0 (up 34.15% YoY) and the FY2025 annual result came in at $355000.0, up 663.49% from the prior year.
- Change in Account Payables was -$411000.0 for Q1 2026 at Apyx Medical, down from -$155000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $756000.0 in Q4 2024 and bottomed at -$776000.0 in Q1 2023.
- A 5-year average of -$1588.2 and a median of -$51000.0 in 2022 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 792.86% in 2023, while the deepest fall reached 1421.57% in 2023.
- Apyx Medical's Change in Account Payables stood at $506000.0 in 2022, then advanced by 26.09% to $638000.0 in 2023, then increased by 18.5% to $756000.0 in 2024, then slumped by 120.5% to -$155000.0 in 2025, then slumped by 165.16% to -$411000.0 in 2026.
- Business Quant data shows APYX's Change in Account Payables at -$411000.0 in Q1 2026, -$155000.0 in Q4 2025, and $328000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Apyx Medical | 170.16 Mn | 139.02 Mn | 7.93 Mn | -411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -411,000.00 |
| Mar 31, 2026 | -411,000.00 |
| Dec 31, 2025 | -155,000.00 |
| Dec 31, 2025 | -155,000.00 |
| Sep 30, 2025 | 328,000.00 |
| Sep 30, 2025 | 328,000.00 |
| Jun 30, 2025 | 513,000.00 |
| Jun 30, 2025 | 513,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Dec 31, 2024 | 756,000.00 |
| Dec 31, 2024 | 756,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Sep 30, 2024 | -474,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | -599,000.00 |
| Mar 31, 2024 | -599,000.00 |
| Dec 31, 2023 | 638,000.00 |
| Dec 31, 2023 | 638,000.00 |